(March 19, 2020) During the Coronavirus times, Chamber Pharma Committee members are coordinating efforts among themselves and with the Ministry of Health to ensure continuous supply of medical and pharmaceutical supplies to the health system, in the event of a lockdown.  

The Committee created a task force to work on the continuation of Clinical Trials ensuring that current clinical trials continue as much as possible uninterrupted.  This involves new procedures and possible delivery of medications directly to patient homes rather than through the medical centers.

If you like to join any of these activities contact Oded Rose.